NCT02231918View on ClinicalTrials.gov

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2007

Conditions
Restless Legs Syndrome
Interventions
DRUG

MIRAPEX® - low

DRUG

MIRAPEX® - medium

DRUG

MIRAPEX® - high

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02231918 - Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS) | Biotech Hunter | Biotech Hunter